Cyclerion Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYCN and other ETFs, options, and stocks.About CYCN
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate.
CEORegina Graul
CEORegina Graul
Employees1
Employees1
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2018
Founded2018
Employees1
Employees1
CYCN Key Statistics
Market cap5.73M
Market cap5.73M
Price-Earnings ratio-1.99
Price-Earnings ratio-1.99
Dividend yield—
Dividend yield—
Average volume56.82K
Average volume56.82K
High today$1.64
High today$1.64
Low today$1.43
Low today$1.43
Open price$1.64
Open price$1.64
Volume64.26K
Volume64.26K
52 Week high$6.25
52 Week high$6.25
52 Week low$1.28
52 Week low$1.28
Stock Snapshot
As of today, Cyclerion Therapeutics(CYCN) shares are valued at $1.50. The company's market cap stands at 5.73M, with a P/E ratio of -1.99.
During the trading session on 2025-12-15, Cyclerion Therapeutics(CYCN) shares reached a daily high of $1.64 and a low of $1.43. At a current price of $1.50, the stock is +4.9% higher than the low and still -8.5% under the high.
Trading volume for Cyclerion Therapeutics(CYCN) stock has reached 64.26K, versus its average volume of 56.82K.
Over the past 52 weeks, Cyclerion Therapeutics(CYCN) stock has traded between a high of $6.25 and a low of $1.28.
Over the past 52 weeks, Cyclerion Therapeutics(CYCN) stock has traded between a high of $6.25 and a low of $1.28.
People also own
Based on the portfolios of people who own CYCN. This list is generated using Robinhood data, and it’s not a recommendation.